Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $120.9900 (-1.41%) ($120.9900 - $122.8600) on Wed. Feb. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 41 | Latest Price | $120.9900(-1.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(62%) IWO(62%) IWM(61%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.64% in a week (0% probabilities). VIXM(-29%) UUP(-20%) VXX(-17%) UNG(-4%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $124.5 | 5 Day Moving Average | $119.46(1.28%) | 10 Day Moving Average | $117.57(2.91%) | 20 Day Moving Average | $124.5(-2.82%) | To recent high | -27.1% | To recent low | 7.2% | Market Cap | $1.944b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |